Widespread dissemination of CTX-M-15 genotype extended-spectrum-β- lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1200-1202

  Chen, Luke F ^a,b   Freeman, Joshua T ^d   Nicholson, Brad ^c   Keiger, Anna ^c   Lancaster, Sarah ^c   Joyce, Maria ^c   Woods, Christopher W ^a,b,c   Cook, Evelyn ^b   Adcock, Linda ^b   Louis, Susan ^b   Cromer, Andrea L ^b   Sexton, Daniel J ^a,b   Anderson, Deverick J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; COMMUNITY HOSPITAL; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENOTYPE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BETA-LACTAMASES; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; GENE EXPRESSION; HOSPITALS, COMMUNITY; HUMANS; KLEBSIELLA; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NORTH CAROLINA; VIRGINIA;

EID: 84893488293     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01099-13     Document Type: Article

References (18)

1. Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L. 2009. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J. Infect. 58:299-307. http://dx.doi.org/10.1016/j. jinf.2009.02.002.
2. Schwaber MJ, Carmeli Y. 2007. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60:913-920. http://dx.doi.org/10.1093/jac/dkm318.
3. Freeman JT, Sexton DJ, Anderson DJ. 2009. Emergence of extendedspectrum-lactamase producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? Clin. Infect. Dis. 49(2):e30-e32. http://dx.doi.org/10.1086/600046.
4. Anderson DJ, Miller BA, Chen LF, Adcock LH, Cook E, Cromer AL, Louis S, Thacker PA, Sexton DJ. 2011. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect. Control Hosp. Epidemiol. 32:315-322. http://dx.doi.org/10.1086/658940.
5. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informationl supplement. CLSI, Wayne, PA.
6. Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Pollock DA, Edwards JR. 2011. National Healthcare Safety Network (NHSN) report, data summary for 2010, device-associated module. Am. J. Infect. Control 39:798-816. http://dx.doi.org/10.1016/j.ajic.2011.10.001.
7. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332. http://dx.doi.org/10.1016/j.ajic.2008.03.002.
8. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739. http://dx.doi.org/10.1128/AAC.00297- 09.
9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
10. Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, Fossum B. 2012. Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand. J. Infect. Dis. 44:641-649. http://dx.doi.org/10.3109/00365548.2012.671956.
11. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM. 2009. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 64:635-641. http://dx.doi.org/10. 1093/jac/dkp220.
12. Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, Korman TM. 2011. Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med. J. Aust. 195:530-533. http://dx.doi.org/10.5694/ mja11.10724.
13. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. http://dx.doi.org/10.1016/S1473-3099(08)70041-0.
14. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A. 2006. Bacteremia due to extendedspectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis. 43:1407-1414. http://dx.doi.org/10.1086/508877.
15. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS, Jr, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. 2013. Community-associated extendedspectrum beta-lactamase- producing Escherichia coli infection in the United States. Clin. Infect. Dis. 56:641-648. http://dx.doi.org/10.1093/cid/cis942.
16. Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, Laupland KB. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286. http://dx.doi.org/10.1128/AAC.01377- 06.
17. Rodriguez-Bano J, Navarro MD, Retamar P, Picon E, Pascual A, Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria G. 2012. Beta-lactam/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin. Infect. Dis. 54:167-174. http://dx.doi.org/10.1093/cid/cir790.
18. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686. http://dx.doi.org/10.1128/ CMR.18.4.657-686.2005. Diseases